NeoGenomics Director Carolyn Starrett Receives Equity Awards

NeoGenomics Inc. director Carolyn S. Starrett received equity awards on June 23, 2026, as reported in this Form 4 filing. The awards include 9,784 stock options with an exercise price of $11.20 per share, vesting on June 1, 2027, and expiring June 1, 2036. Additionally, she received 14,125 restricted stock units that vest on June 1, 2027, with the shares not subject to expiration once vested. Both awards were granted at $0 cost to the director. Following these transactions, Starrett holds 9,784 stock options and 14,125 restricted stock units. The filing was signed by attorney-in-fact Ali Olivo on June 25, 2026, and represents standard director compensation through equity awards.